Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05994404 · ClinicalTrials.gov registry record
Cervical Spondylotic Myelopathy - Cost Observational Surgical Trial
A clinical trial of Cervical Spondylosis With Myelopathy, sponsored by Lahey Clinic.
- Completed
- Registry status
- 269
- Enrollment target
- 2
- Study locations
NCT05994404: Completed study of Cervical Spondylosis With Myelopathy, sponsored by Lahey Clinic.
NCT05994404 is a study of Cervical Spondylosis With Myelopathy that has completed, run by Lahey Clinic. The registered enrollment target is 269 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05994404, a study of Cervical Spondylosis With Myelopathy, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- 269 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the cost-effectiveness of different surgical strategies to treat cervical spondylotic myelopathy. The study will use data generated from the CSM-S Trial (NCT02076113). 1. To determine if laminoplasty is more cost-effective compared to dorsal fusion or ventral fusion surgery. 2. To determine the relative cost-effectiveness between anterior cervical discectomy and fusion (ACDF), posterior instrumented cervical fusion (PCF), and cervical laminoplasty.
Primary Outcome
Index hospitalization costs+one-year all cause costs+loss of productivity costs
Conditions Studied
Interventions
- PROCEDURE ACDF
- PROCEDURE Posterior Cervical Fusion
- PROCEDURE Cervical Laminoplasty
Study Locations (2)
Massachusetts
- Lahey Hospital & Medical Center - Burlington
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2019-04-01 |
What the finished NCT05994404 record still lists
NCT05994404 is an observational study that tracks outcomes without assigning an intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cervical Spondylosis With Myelopathy appearing as the primary indexed condition, and to 3 interventions - of which ACDF is the first listed.
NCT05994404 reports a single indexed study location in Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05994404 about?
NCT05994404 is a clinical study titled "Cervical Spondylotic Myelopathy - Cost Observational Surgical Trial". The purpose of the study is to determine the cost-effectiveness of different surgical strategies to treat cervical spondylotic myelopathy. The study will use data generated from the CSM-S Trial (NCT02076113). 1. To determine if laminoplasty is more cost-effective compared to dorsal fusion or ventra...
What is the current status of trial NCT05994404?
This trial is currently completed. The enrollment target is 269 participants. The study started on 2014-04-01. Estimated completion is 2019-04-01.
What conditions does trial NCT05994404 study?
This clinical trial studies the following conditions: Cervical Spondylosis With Myelopathy.
What interventions are being tested in trial NCT05994404?
The interventions under investigation include: ACDF (PROCEDURE), Posterior Cervical Fusion (PROCEDURE), Cervical Laminoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT05994404?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05994404 being conducted?
This trial has 2 study locations across Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Spondylosis With Myelopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04802291 · 269 participants · NA
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
- NCT06500455 · 269 participants · Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
- NCT06630676 · 269 participants · NA
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI